Hidden Chemical Pattern Could Unlock Next Generation of Drug Breakthroughs

Researchers have identified why certain molecular structures called PFAS motifs perform better in drug design, potentially accelerating development of new therapies. The finding could reshape how pharmaceutical companies screen and optimize candidate compounds, reducing costly failures in early-stage development.

Originaltitel: Driving Breakthrough Therapies: Why PFAS Motifs Matter in Drug Design